Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-25 Sale | 2026-02-26 6:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 620 | $486.35 | $301,537 | 7,284 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 3,619 | $484.31 | $1,752,704 | 8,486 (Direct) | View |
| 2026-02-11 Sale | 2026-02-12 4:56 pm | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 2,021 | $460.43 | $930,529 | 12,914 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-24 Tax Withholding | 2026-02-26 6:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 582 | $485.11 | 7,284 (Direct) | View |
| 2026-02-17 Tax Withholding | 2026-02-19 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 1,110 | $483.75 | 8,486 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 2,584 | $0 | 8,486 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 4:32 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 2,283 | $487.76 | 10,631 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:56 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 1,127 | $468.41 | 12,914 (Direct) | View |
Ownership | 2026-02-03 4:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bunnage Mark E. EVP, Chief Scientific Officer | 0 | $0 | 16,062 (Direct) | View |